Andrea Panunzio

About

No biography available yet.

Research Focus

Key Achievements

Top Papers

1. 1
   Advanced age portends poorer prognosis after radical prostatectomy: a single center experience

   30 citations · 2022
2. 2
   The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy

   19 citations · 2020
3. 3
   Outcomes of robotic‐assisted versus open radical cystectomy in a large‐scale, contemporary cohort of bladder cancer patients

   19 citations · 2022
4. 4
   Predictive Factors of the Risk of Long-Term Hospital Readmission after Primary Prostate Surgery at a Single Tertiary Referral Center: Preliminary Report

   14 citations · 2020
5. 5
   American Society of Anesthesiologists (ASA) physical status system predicts the risk of postoperative Clavien–Dindo complications greater than one at 90 days after robot-assisted radical prostatectomy: final results of a tertiary referral center

   13 citations · 2022
6. 6
   Regional differences in total hospital costs for radical cystectomy in the United States

   13 citations · 2023
7. 7
   Open approach, extended pelvic lymph node dissection, and seminal vesicle invasion are independent predictors of hospital readmission after prostate cancer surgery: a large retrospective study

   11 citations · 2020
8. 8
   Advanced age is an independent prognostic factor of disease progression in high-risk prostate cancer: results in 180 patients treated with robot-assisted radical prostatectomy and extended pelvic lymph node dissection in a tertiary referral center

   5 citations · 2023
9. 9
   Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?

   4 citations · 2024
10. 10
    The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b

    4 citations · 2024

Key Collaborators